act in Biological Technology
Navigation Links
act in Biological Technology
PharmSource Information Services, Inc. announces the publication of a new white paper - "The U.S. Foreign Corrupt Practices Act (FCPA): How to Minimize Your Risk." This incisive resource provides guidelines on how to establish a strong FCPA compliance program that minimizes corruption r...
NEW YORK, April 21 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc. The full 56-page report can be found at www.crystalra.com . ACT Biotech, Inc. ("ACT Biotech" or "the Company") is a cl...
INDIANAPOLIS, March 17 /PRNewswire-FirstCall/ -- Today Eli Lilly and Company (NYSE: LLY ) announced its support for the Pathway for Biosimilars Act. The U.S. has a 25-year history of success with laws promoting the discovery of new, chemical-based medicines and providing an abbreviated approval...
...ation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events...
..." "intends," "expects" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform act of 1995 and constitute "forward-looking information" within the meaning of applicable Canadian securities laws. All such statements are made pursuant ...
NEW YORK, April 21 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc. The full 56-page report can be found at www.crystalra.com . ACT Biotech, Inc. ("ACT Biotech" or "the Company") is a cl...
INDIANAPOLIS, March 17 /PRNewswire-FirstCall/ -- Today Eli Lilly and Company (NYSE: LLY ) announced its support for the Pathway for Biosimilars Act. The U.S. has a 25-year history of success with laws promoting the discovery of new, chemical-based medicines and providing an abbreviated approval...
China-Biotics, Inc. Retains KPMG for the Implementation of Sarbanes-Oxley Act Section 404
SHANGHAI, China, Oct. 16 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced that it h...A new material could act as a nanofridge for microchips
In the past few years, the design and manufacturing of circuits at nanoscopic scale for integrated devices has become one of the frontier fields in new material science and technology. The significant reduction achieved in these devices often is accompanied by new discoveries in how they behave pr...Tethered molecules act as light-driven reversible nanoswitches
Our ability to see is based on molecules in the eye that flip from one conformation to another when exposed to visible light. Now, a new technique for attaching light-sensitive organic molecules to metal surfaces allows the molecules to be switched between two different configurations in response...Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
WALTHAM, Mass., May 21 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI ), today expressed praise for the passage into law of the Genetic Information Nondiscrimination Act (GINA). The bill was approved unanimously in the Senate on April 25, 2008, and signed into law by Presiden...'Two-Faced' Particles Act Like Tiny Submarines
RALEIGH, N.C., Feb. 29 /PRNewswire-USNewswire/ -- For the first time, researchers at North Carolina State University have demonstrated that microscopic "two-faced" spheres whose halves are physically or chemically different -- so-called Janus particles -- will move like stealthy submarines whe...'2-faced' particles act like tiny submarines
For the first time, researchers at North Carolina State University have demonstrated that microscopic "two-faced" spheres whose halves are physically or chemically different so-called Janus particles will move like stealthy submarines when an alternating electrical field is applied to liquid sur...Arno Therapeutics to Deregister its Common Stock under the Exchange Act
PARSIPPANY, N.J., May 4 /PRNewswire-FirstCall/ -- Arno Therapeutics, Inc. (OTC Bulletin Board: ARNI), a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced that it has voluntarily filed a Form 15 with the Securities and Exchange Commission ("SEC") in order to...The impact of ACT 255 on the future of high-tech investment in Wisconsin
Act provides $6.5 million a year for 10 years in tax credits MADISON The future of venture capital and investment in Wisconsin was discussed at an economic development breakfast panel discussion presented last Wednesday by the UW-Madison Small Business Development Center at the MG&E Innovati...Five more companies eligible for Act 255 investor tax credits
Potential investors in five more Wisconsin companies qualify for tax credits under Act 255 , legislation passed last year to provide financial assistance to start-up companies, Governor Jim Doyle said on Friday. One of the act's provisions allows angel and venture investors to claim tax credits...Milwaukee firm among first to use Act 255 tax credits in investor pitch
Milwaukee Neurognostics , a home-grown Milwaukee medical device company, finished a funding round on Friday that was one of the first to take advantage of Wisconsin's new tax credits for investors, which can give back up to 25 percent of an investment. Neurognostics oversubscribed on its $1 ...More firms outside Madison eligible for Act 255 tax credits
Four more firms have qualified for investor tax credits under Wisconsin's Act 255. That includes several firms outside the Madison area, where most eligible companies so far have come from. Wisconsin gives the tax credits to investors on money put into eligible companies. StrandVision , in Eau...Proposed Illinois broadband act falls short
Last week, I was sent an announcement of pending Illinois broadband legislation (20 ILCS 3921/10), which was announced on Jan. 25. Here's its synopsis: Creates the Universal Access to Broadband Services Act. Requires the Department of Central Management Services (CMS) to create and maintain a map...Was the Telecom Act of 1996 a boon or bomb for U.S.?
The Telecom Act of 1996 was enacted to promote competition. It was supposed to create certain funds for universal service and to develop a better infrastructure. Ten years later, can we say this was good for America? How much money was wasted? Did we ever really achieve the open competition the...Burke would like to double Act 255 angel tax credits
State commerce secretary Mary Burke said this week that she would like Wisconsin to double the amount of tax credits available to angel investors under the Act 255 program. In an interview, Burke said funding increases would be contingent on the state's fiscal health, but she would like to doubl...A heavenly tax cut: Act 255 stimulates economic growth
Sometimes, legislators like me can focus too much on the bad things happening in our state. We spend a lot of time talking about our oppressive tax burden, out of control spending by state government, a regulatory scheme that stifles business development and an economy that is growing more slowly...Senate Democrats strip additional Act 255 funding from budget
Madison, Wis. - Lost amid the controversy over its proposed overhaul of the state's healthcare system was the vote by the State Senate Democratic Caucus to pare back additional funding for the Act 255 tax credit program that was included in the budget approved by the Joint Committee on Finance. ...Innovation expert speaks on the business-IT balancing act
Tom Koulopoulos is founder and CEO of the Delphi Group, a Boston-based consultancy focused on biztech leadership and strategy, and director of Perot Systems' Innovation Lab. He will arrive in Madison, Wisconsin this February to speak at the Fusion 2007 CEO-CIO Symposium . We asked him to share so...DOE awards $377 million in funding for 46 energy frontier research centers
... EFRCs, $277 million comes from funding made available through the Recovery act with the remaining $100 million made from DOE's FY2009 budget. The 46 EFRC...d nuclear energy. EFRCs funded by the American Recovery and Reinvestment act include: Arizona State University (Tempe, AZ) $14 million for five ye...KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid
...II, Section 12 of the Company's By-Laws (requiring a stockholder seeking to act by written consent to request that the Board fix a record date with respect...ithin the meaning of the United States Private Securities Litigation Reform act of 1995 ("PSLRA") and which may be based on or include assumptions concerni...Schering-Plough Shareholders Approve Merger With Merck
...pplicable waiting period under the Hart-Scott-Rodino Antitrust Improvements act of 1976, as amended, as well as clearance by the European Commission under ... statements" within the meaning of the Private Securities Litigation Reform act of 1995. Forward-looking statements do not relate strictly to historical o...REPEL-CV(TM) Adhesion Barrier Receives Endorsement of Kids With Heart
...ase that are not statements of historical fact, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform act of 1995. Reference is made to the c om pany's Annual Report on Form 10-KSB for the year ended December 31, 2008, for a description of these, as wel...SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results
...release contains forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform act of 1995. These forward-looking statements involve risks and uncertainties, including activities, events or developments tha t we expect, believe or a...NeurogesX Reports Second Quarter 2009 Results
... in December 2008 and has been given an extended Prescription Drug User Fee act (PDUFA) date of November 16, 2009. NeurogesX' second most advanced p...looking statements for purposes of the Private Securities Litigation Reform act of 1995 (the "Act"). NeurogesX disclaims any intent or obligation to update...AutoImmune Inc. Reports 2009 Second Quarter Financial Results
...t are not strictly historical are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform act of 1995. These statements include statements about clinical trials and studies and future sales, royalties and revenue. You can identify these forwar...ThermoGenesis Announces Expanded Collaboration With Celling Technologies
...e contains forward-looking statements, and such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform act of 1995. These statements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward...Synthetech Reports First Quarter Fiscal 2010 Results
... Forward-Looking Statements This press release contains "forward looking" statements within the meaning of the Private Securities Litigation Reform act of 1995. All statements, other than statements of historical fact, are forward-looking, including, without limitation, statements regarding: future o...ThermoGenesis Provides Update on Fiscal 2009 Results
...e contains forward-looking statements, and such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform act of 1995. These statements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward...InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
... Forward-Looking Statements This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitatio...SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
...s under "2009 Guidance," are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the ris...OncoGenex Reports Second Quarter 2009 Financial Results
... This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform act of 1995, including, but not limited to, statements regarding the intended use and sufficiency of the Company's cash, cash equivalents and short-term i......ation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results, and the timing of events...
China Sky One Medical, Inc. Appoints New Independent Director
... expert" as defined by the SEC rules adopted pursuant to the Sarbanes-Oxley act of 2002. Mr. Wei Lee has over 15 years of experience in financial se...g statements within the meaning of the Private Securities Litigation Reform act of 1995. These statements can be identified by the use of forward- looking ......" "intends," "expects" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform act of 1995 and constitute "forward-looking information" within the meaning of applicable Canadian securities laws. All such statements are made pursuant ...
Repligen Reports First Quarter Fiscal Year 2010 Financial Results
...ade pursuant to the safe harbor provisions of Section 27A of the Securities act of 1933, as amended, and Section 21E of the Securities Exchange act of 1934, as amended. The forward-looking statements in this release do not ...NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
... (FDA) has extended the Prescription Drug User Fee act (PDUFA) date from August 16, 2009 to November 16, ... been given an extended Prescription Drug User Fee act (PDUFA) date of November 16, 2009. Neurog...rposes of the Private Securities Litigation Reform act of 1995 (the "Act"). NeurogesX disclaims any inten...Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
... For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform act of 1995. Among the factors that could cause our actual results to differ materially are the following: There can be no assurance that the Company will...Amicus Therapeutics Announces Second Quarter 2009 Financial Results
... statements" within the meaning of the Private Securities Litigation Reform act of 1995 relating to preclinical and clinical development of Amicus' candida...arbor provisions of Section 21E of the Private Securities Litigation Reform act of 1995. FOLD-G Table 1 Amic...Other TagsKATKATKATKATLaseLaseLaseLaseLaseOther Contentschromatidschromatidssistersistersistersistersistersisterspecificspecificspecificspecificspecificspecificspecificspecificspecificspecificskeletalskeletalskeletalskeletalskeletalskeletalskeletalskeletalskeletalmoldsmoldsmoldsmoldsmoldsmoldsslimeslimeintestineintestineintestineintestineintestineintestinesmallsmallsmallsmallsmallsmallsmallsmallsmallsmall
(Date:12/3/2009)Have you ever felt overly upset by a social snubbing? Your genetics, not your friends, may be at fault. , Scientists have long known that opium-like painkillers, called opioids, relieve not only phys
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Grooving down the helix 2Grooving down the helix 3Power Plate 28R 29 Opens Cutting Edge Studio in L A 49383 1Power Plate 28R 29 Opens Cutting Edge Studio in L A 49383 2Benefit of glinides is not proven 49380 1Benefit of glinides is not proven 49380 2Benefit of glinides is not proven 49380 37th annual 5BBC 5D2 Basel Computational Biology Conference Molecular Evolution June 18 19 2009 8899 17th annual 5BBC 5D2 Basel Computational Biology Conference Molecular Evolution June 18 19 2009 8899 27th annual 5BBC 5D2 Basel Computational Biology Conference Molecular Evolution June 18 19 2009 8899 3(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2[0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification[0] Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto[0] Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference[0] BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use[0] News brief -- childhood cancer survivor study report: Late recurrence is a risk for some cancers
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |